Quote this publication Share Print

Usefulness of contrast-enhanced mammography in breast cancer diagnosis strategy - INAHTA Brief

Health technology assessment - Posted on Nov 22 2021

HAS has assessed contrast-enhanced mammography (CEM) in the breast cancer diagnosis strategy to issue an opinion on listing the procedure in the joint classification of medical procedures. The aim of the assessment was to i) compare the diagnostic performances of contrast-enhanced mammography to breast MRI in certain indications, ii) to evaluate safety in relation to exposure to ionising radiation and to reactions secondary to iodinated contrast agent injection, iii) to evaluate the impact of CEM on the therapeutic strategy and iv) to assess organisational impacts of CEM

Contact Us

Évaluation des actes professionnels